Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNMCN.L Regulatory News (NMCN)

  • There is currently no data for NMCN

Director/PDMR Shareholding

8 Feb 2016 07:00

RNS Number : 3066O
North Midland Construction PLC
08 February 2016
 

North Midland Construction plc (the "Company")

Director's Dealing

 

The Company was notified on 5 February 2016 that Andrew David Langman, a Director of the Company, transferred a number of ordinary shares of 10 pence each in the Company ("Ordinary Shares") to his Self-Invested Personal Pension (SIPP).

On 29 January 2016, he sold 13,453 Ordinary Shares at a price of 113 pence per share. On the same day, his SIPP purchased 13,349 Ordinary Shares at a price of 113.20 pence per Ordinary Share.

As a result of this transaction, Andrew Langman's beneficial holding is now 189,941 Ordinary Shares which represents approximately 1.9% of the Company's issued share capital.

 

Contacts:-

North Midland Construction PLC

Robert Moyle, Chairman 01623 515008

Dan Taylor, Finance Director

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBGGDDIXGBGLL
Date   Source Headline
6th Oct 20215:49 pmRNSAppointment of Administrators
4th Oct 20215:30 pmRNSNMCN
4th Oct 202112:26 pmRNSNotice of intention to appoint administrators
1st Oct 20214:19 pmRNSUpdate on publication of the Group's annual report
24th Sep 202110:07 amRNSUpdate on results, refinancing and proposed move
25th Aug 20212:50 pmRNSUpdate on 2020 Results, Prospectus and Circular
2nd Aug 20212:51 pmRNSUpdate on 2020 results
20th Jul 20212:06 pmRNSUpdate on 2020 Result, Financing and Result of GM
15th Jul 20218:21 amRNSGeneral Meeting Details
29th Jun 20218:00 amRNSUpdate on 2020 results, temporary suspension
29th Jun 20217:30 amRNSSuspension - NMCN PLC
24th Jun 20217:00 amRNSPosting of Circular and notice of General Meeting
22nd Jun 20219:05 amRNSSecond Price Monitoring Extn
22nd Jun 20219:00 amRNSPrice Monitoring Extension
21st Jun 20217:00 amRNSFinancing Update
14th Jun 20217:00 amRNSFinancing and Trading Update
7th Jun 20217:00 amRNSHolding(s) in Company
28th May 20212:06 pmRNSSecond Price Monitoring Extn
28th May 20212:00 pmRNSPrice Monitoring Extension
28th May 202111:05 amRNSSecond Price Monitoring Extn
28th May 202111:00 amRNSPrice Monitoring Extension
28th May 20217:00 amRNSFinancing and Trading Update
17th May 20217:00 amRNSAppointment of new Chief Executive Officer
16th Apr 20213:21 pmRNS£8.9m facility concluded & Notice of results
12th Apr 20217:00 amRNSAppointment of new Chief Executive Officer
6th Apr 20217:00 amRNSFinancing Update
31st Mar 20217:01 amRNSFinancing Update
4th Mar 202112:19 pmRNSDirectorate Change
26th Feb 20219:54 amRNSResult of General Meeting
23rd Feb 20211:23 pmRNSTrading Update and Notice of Results
3rd Feb 20217:00 amRNSPosting of Circular and Notice of General Meeting
28th Jan 20217:00 amRNSAppointment of CEO
23rd Dec 202012:00 pmRNSAppointment of Financial Adviser and Broker
23rd Dec 20207:00 amRNSTrading & Board Change Update
28th Oct 20208:23 amRNSAppointment of new Chief Financial Officer
15th Oct 20207:00 amRNSTrading Update
29th Sep 20203:11 pmRNSExternal Auditor Appointment
24th Sep 20204:30 pmRNSBoard Changes and Trading Update
9th Sep 202011:00 amRNSAppointment of Company Secretary
28th Aug 202012:12 pmRNSBoard Changes - Update
7th Aug 20207:04 amRNSProgressive publishes new research
6th Aug 20207:00 amRNSHalf Year Report
24th Jul 202010:00 amRNSBoard Change
25th Jun 20204:19 pmRNSResult of Annual General Meeting
25th Jun 20207:00 amRNSAGM Trading Update
27th May 20207:00 amRNS2019 Report & Accounts & 2020 AGM Notice posted
21st May 20207:00 amRNSDisclosure of rights attached to Equity Shares
4th May 202011:16 amRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNS2019 Final Results & Further COVID-19 Update
14th Apr 202010:00 amRNSFurther Covid-19 Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.